SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Jurgis Bekepuris who wrote (60371)2/11/2018 8:57:49 PM
From: Spekulatius  Read Replies (4) | Respond to of 78702
 
largest positions for me are
ENB complex (EN, SEP, EEQ)
MNPP (real estate in NYC etc)
BRK.B, AXS, RE (a Bit Fairfax)- insurer
WPZ, WMB, BWP- pipelines, MLPs
GRVO. PA (selling this one down)

recent buy/ads were: ENB, SEP, GE (ouch!) and Fang stocks GOOG and FB

My intent is to increase exposure to fang stocks FB and GOOG on weakness which I think are cheap.



To: Jurgis Bekepuris who wrote (60371)2/13/2018 4:25:31 PM
From: Graham Osborn  Read Replies (1) | Respond to of 78702
 
I just noticed that Fairfax's LT debt has been higher than their tangible book since last March. That makes them no longer "conservatively financed" under my usual definition. That's a never for Berkshire and a first for Fairfax - Prem has always been more of a financier than Buffett but I'm surprised he let it get so high.



To: Jurgis Bekepuris who wrote (60371)3/6/2018 2:02:33 AM
From: Jurgis Bekepuris  Read Replies (1) | Respond to of 78702
 
My top (>2%) positions in no particular order: BRKB, FRFHF, ISTB, JPM, EXXRF, LSXMA, DISCK, TESB.BE, LVNTA, MKL, AAPL
In:
Out:

Fixed income: 10%
Cash: 6%
Sectors (kinda): Insurance(FRFHF, BRK, MKL): 22%, Malone/media: 16%, Banks/financials: 9%, Oil: 2%, Medical/pharma: 2%, Tech: 10%, Various owner-operators (not included in other categories): 16%

New positions:
Positions increased: FB
Positions reduced:
Positions eliminated: LCSHF
Flip-flop:

Uneventful month - at least in the portfolio. :)

Added a bit FB.

Sold LCSHF based on 2017 results. The thesis was that LCSHF should have better underwriting results compared to other companies, since they wrote less business because of unattractive prices. Their results for 2017 were bad though. Which raised the question: why hold it if the original thesis does not seem to be true?